Igrene (ABI) investor relations material

Executive summary

• Operating loss for the period was -3,558 KSEK, an improvement from -5,030 KSEK year-over-year.

• Net result after financial items was -3,525 KSEK compared to -5,029 KSEK in the previous year.

• Strategic focus on extracting hydrogen and carbon from fossil-free methane, with a demonstration plant planned in collaboration with SEID AS.

• The company’s technology and project have received EU financial support and innovation awards.

Financial highlights

• Revenue for the period was 2 KSEK, up from 0 KSEK year-over-year.

• Total costs decreased to 3,560 KSEK from 4,957 KSEK year-over-year.

• Earnings per share improved to -0.03 SEK from -0.05 SEK year-over-year.

• Cash and cash equivalents at period end were 1,374 KSEK, down from 8,381 KSEK a year earlier.

• Equity at period end was 22,436 KSEK, with a high equity ratio of 95.9%.

Outlook and guidance

• The company aims to commercialize its methane-to-hydrogen and carbon technology, targeting both domestic and international markets.

• Ongoing regulatory processes in Sweden may impact future operations and market access.